Skip to main content
NCBI home page
Trials logoLink to Trials
. 2020 Feb 12;21:172. doi: 10.1186/s13063-020-4107-8

Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

Frank Tegtmeier 1, Reinhard Schinzel 1,✉, Ronny Beer 2, Diederik Bulters 3, Jean-Yves LeFrant 4, Joan Sahuquillo 5, Andreas Unterberg 6, Peter Andrews 7, Antonio Belli 8, Javier Ibanez 9, Alfonso Lagares 10, Michael Mokry 11, Harald Willschke 12, Charlotte Flüh 13, Erich Schmutzhard 2; on behalf of the NOSTRA Investigators
PMCID: PMC7014658  PMID: 32051020

Correction to: Trials (2020) 21:80

https://doi.org/10.1186/s13063-019-3965-4

After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.

  • Original name spelling:

    Charlotte Flühe

  • Correct name spelling:

    Charlotte Flüh

The original article has been corrected.

Reference

  • 1.Tegtmeier, et al. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials. 2020;21:80. doi: 10.1186/s13063-019-3965-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES